Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01822314 |
|---|---|
| Brief Title: | Neoadjuvant Chemotherapy With Nab-paclitaxel in Women With HER2-negative High-risk Breast Cancer (ETNA) |
| First Submitted : | March 25, 2013 |
| First Submitted that Met QC Criteria : | March 27, 2013 |
| First Posted : | April 2, 2013 (Estimate) |
| Last Update Submitted that Met QC Criteria : | March 5, 2024 |
| Last Update Posted : | March 7, 2024 |